Abstract
Purpose
Histological vascular invasion (VI) by tumors is a risk factor for recurrence after surgical resection. However, VI features vary histologically. The aim of this study was to identify characteristic VI features that are associated with recurrence in squamous cell carcinoma (SCC) of the lung.
Methods
We enrolled 149 patients with pathological stage I primary lung SCC in this study and examined whether the presence, frequency, and size of VI were associated with recurrence. We also evaluated immunophenotypes of carcinoma cells and stromal cells within VI areas.
Results
Of the 149 patients, 58 had tumors with VI. The presence of VI was significantly correlated with shorter recurrence-free survival (RFS) (P = 0.018). Although VI frequency was not associated with RFS, larger VI size (>425 µm) was significantly correlated with shorter RFS (P = 0.003). Carcinoma cells within larger VI areas expressed significantly higher levels of podoplanin, cancer stem cell marker (P = 0.039); higher numbers of CD34+ microvessels (P = 0.009), CD204+ macrophages (P = 0.026), and α-SMA+ myofibroblasts (P = 0.056) were present within larger VI areas than within smaller VI ones.
Conclusions
Our results indicate that larger VI areas are a predictor for recurrence in lung SCC; also, within the larger blood vessel, cancer stem cells and abundant stromal cells can create a more favorable microenvironment for tumor metastasis.
Similar content being viewed by others
References
Atsumi N, Ishii G, Kojima M, Sanada M, Fujii S, Ochiai A (2008) Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem Biophys Res Commun 373:36–41. doi:10.1016/j.bbrc.2008.05.163
Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615–5621. doi:10.1158/1078-0432.ccr-06-0169
Bodendorf MO, Haas V, Laberke HG, Blumenstock G, Wex P, Graeter T (2009) Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Lung cancer (Amsterdam, Netherlands) 64:71–78. doi:10.1016/j.lungcan.2008.07.011
Davis SJ, Divi V, Owen JH, Bradford CR, Carey TE, Papagerakis S, Prince ME (2010) Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 136:1260–1266. doi:10.1001/archoto.2010.219
Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Jain RK (2010) Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 107:21677–21682. doi:10.1073/pnas.1016234107
Gabor S, Renner H, Popper H, Anegg U, Sankin O, Matzi V, Lindenmann J, Smolle Juttner FM (2004) Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. Eur J Cardiothorac Surg 25:439–442. doi:10.1016/j.ejcts.2003.11.033
Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323. doi:10.1016/j.stem.2007.06.002
Kaseda K, Ishii G, Aokage K, Takahashi A, Kuwata T, Hishida T, Yoshida J, Kohno M, Nagai K, Ochiai A (2013) Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma. Cancer Sci 104:1262–1269. doi:10.1111/cas.12219
Kessler R, Gasser B, Massard G, Roeslin N, Meyer P, Wihlm JM, Morand G (1996) Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 62:1489–1493. doi:10.1016/0003-4975(96)00540-1
Kinoshita T, Ohtsuka T, Yotsukura M, Asakura K, Goto T, Kamiyama I, Otake S, Tajima A, Emoto K, Hayashi Y, Kohno M (2015) Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung. J Thorac Oncol 10:619–628. doi:10.1097/jto.0000000000000480
Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhauser FD, Shariat SF, Lang H, Rioux-Leclerq N, Remzi M, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ (2012) Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol 187:418–423. doi:10.1016/j.juro.2011.10.024
Kunita A, Kashima TG, Morishita Y, Fukayama M, Kato Y, Tsuruo T, Fujita N (2007) The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am J Pathol 170:1337–1347. doi:10.2353/ajpath.2007.060790
Lee AK, DeLellis RA, Silverman ML, Heatley GJ, Wolfe HJ (1990) Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8:1457–1465
Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K (2010) Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients. Thorax 65:1092–1098. doi:10.1136/thx.2010.141861
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444. doi:10.1038/nature07205
Miyoshi K, Moriyama S, Kunitomo T, Nawa S (2009) Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 137:429–434. doi:10.1016/j.jtcvs.2008.07.007
Nian WQ, Chen FL, Ao XJ, Chen ZT (2011) CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics. Mol Cell Biochem 355:241–248. doi:10.1007/s11010-011-0860-z
Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Tateno H (1996) Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 78:2313–2317
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437. doi:10.1038/nm.3394
Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E (2010) Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol 17:1311–1323. doi:10.1245/s10434-009-0895-5
Rigau V, Molina TJ, Chaffaud C, Huchon G, Audouin J, Chevret S, Brechot JM (2002) Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung cancer (Amsterdam, Netherlands) 38:169–176
Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N (2012) Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection. J Thorac Oncol 7:1263–1270. doi:10.1097/JTO.0b013e31825cca6e
Tsuchiya T, Akamine S, Muraoka M, Kamohara R, Tsuji K, Urabe S, Honda S, Yamasaki N (2007) Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung cancer (Amsterdam, Netherlands) 56:341–348. doi:10.1016/j.lungcan.2007.01.019
Turhan K, Samancilar O, Cagirici U, Goksel T, Nart D, Cakan A, Cok G (2010) The effect of blood vessel invasion on prognosis of operated stage I non-small cell lung cancer patients. Thorac Cardiovasc Surg 58:28–31. doi:10.1055/s-0029-1185881
Usui S, Minami Y, Shiozawa T, Iyama S, Satomi K, Sakashita S, Sato Y, Noguchi M (2013) Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma. Lung Cancer 82:407–412. doi:10.1016/j.lungcan.2013.09.001
Acknowledgments
This work was supported by the National Cancer Center Research and Development Fund (23-A-10).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interests to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hisakane, K., Saruwatari, K., Fujii, S. et al. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma. J Cancer Res Clin Oncol 142, 593–600 (2016). https://doi.org/10.1007/s00432-015-2068-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-015-2068-1